Go Pro
OTCMKTS:AJINY

Ajinomoto Q1 2025 Earnings Report

Ajinomoto logo
$27.96 0.00 (0.00%)
As of 07/8/2026

Ajinomoto EPS Results

Actual EPS
$0.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ajinomoto Revenue Results

Actual Revenue
$2.34 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ajinomoto Announcement Details

Quarter
Q1 2025
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Ajinomoto Earnings Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More Ajinomoto Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ajinomoto? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ajinomoto and other key companies, straight to your email.

About Ajinomoto

Ajinomoto (OTCMKTS:AJINY) Co., Inc. is a Tokyo-based multinational food and chemical company best known for commercializing monosodium glutamate (MSG) after Professor Kikunae Ikeda identified the flavor enhancer associated with umami in the early 20th century; the company was founded in 1909. Over more than a century it has grown from its seasoning roots into a diversified group that develops, manufactures and markets food products, seasonings and ingredient solutions for both retail and foodservice customers.

Today Ajinomoto’s activities span prepared and frozen foods, retail seasonings and condiments, and a broad range of amino acid-based products and specialty chemicals. Its amino-acid technologies are applied across food and beverage formulation, animal nutrition, pharmaceutical and medical nutrition products, and industrial uses. The company also participates in health-and-wellness initiatives by producing ingredients used in clinical nutrition, supplements and pharmaceutical applications, while continuing significant operations in processed and frozen consumer foods.

Ajinomoto operates globally with a strong presence in Japan and throughout Asia and expanding operations in the Americas, Europe and other regions through manufacturing, sales subsidiaries and R&D centers. Headquartered in Tokyo, the company maintains an international footprint of production and research facilities and markets products under a variety of brand names. Ajinomoto securities trade internationally, including as an OTC-listed instrument under the symbol AJINY, reflecting its cross-border investor access.

View Ajinomoto Profile